Goff Brian 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Goff Brian（CIK 1546216）在 2 家公司共报告 22 笔 SEC Form 4 内部人交易（最近一笔 2026-06-10）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-10 | Intellia Therapeutics, Inc. (NTLA) | 董事 | 买入 | 9,200 | $0 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 25,528 | $0 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 12,472 | $432,903 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 13,500 | $0 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 6,596 | $228,947 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 8,500 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 3,870 | $112,075 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 18,000 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 8,267 | $239,412 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 13,000 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 5,918 | $171,385 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 25,528 | $0 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 12,473 | $337,894 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 12,750 | $0 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 6,230 | $168,771 |
| 2025-08-12 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 22,691 | $0 |
| 2025-08-12 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 11,085 | $406,487 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 25,527 | $0 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 12,471 | $418,277 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 买入 | 12,750 | $0 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Executive Officer | 卖出 | 6,229 | $208,921 |
| 2025-06-13 | Intellia Therapeutics, Inc. (NTLA) | 董事 | 买入 | 8,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-10